img

Get a Call

Market News

  • 13

    Apr
    2019

    Suven to buy assets of Rising Pharmaceuticals through JV partner Shore Suven Pharma

    Suven Life Sciences announced that it has received the US Bankruptcy Court approval of Stalking Horse Agreement to buy the assets of Rising Pharmaceuticalsthrough its joint venture partner Shore Suven Pharma Inc.

    The sale was conducted through a Court-supervised process under Section 363 of theBankruptcy Code. Under that process, Shore Suven Pharma`s purchase agreement servedas the stalking horse agreement and an auction would have been conducted had theCompany received qualified offers from other bidders reflecting potentially higher and/orotherwise better terms. No such bids were received prior to the bid deadline. Therefore,no auction was conducted and Shore Suven Pharma was selected as the successful bidderfor the Rising Pharmaceuticals on 29 March 2019. The transaction is expected to closeon 19 April 2019, subject to the satisfaction of certain other conditions.

    Powered by Capital Market - Live News

NIFTY 11679.30 img 7.15

SENSEX 39007.48 img 46.69

GOLD 32914.00

SILVER 37009.00

1 USD / INR 69.69

Attention Investors! "Prevent Unauthorised Transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of Investors."           Attention Investors! "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day. Issued in the interest of investors."           "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."           "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."           "As per SEBI guidelines, old DIS cannot be accepted for execution of instruction with effect from 07-01-2016. Kindly submit requisition slip / letter for issuance of new DIS booklet at our corporate office address to avoid rejection of your instruction(s) on or after 07-01-2016.”            "In accordance with the Union Budget 2017-18 announcement, SEBI has advised to link Aadhar with individual demat accounts. Kindly submit details of Aadhar number along with copy of Aadhar Card.”          

Copyright © 2019. All Rights Reserved. Indiabulls Ventures Limited. | Cookie Policy | Bechmark Rates | Disclaimer | Terms and Condition | Blog

Indiabulls Ventures Limited. [Corporate Identification Number for IVL: L74999DL1995PLC069631]
SEBI Reg No: INZ000007534 | NSE Membership No: 08756 [CM, FNO, CDS] | BSE Membership No: 907 [CM, FNO]
Indiabulls Securities Limited (Formerly known as Indiabulls Commodities Limited) [Corporate Identification Number for ISL: U74999DL2003PLC122874]
SEBI Reg No: INZ000036136 | MCX: MEMBER CODE: 12835 | NCDEX: MEMBER CODE: 10
Registered office address: M - 62 & 63, First Floor, Connaught Place, New Delhi - 110001.
Correspondence office address: Indiabulls House, 448 – 451, Udyog Vihar, Phase – V, Gurgaon – 122016, Haryana.
Site best viewed in IExplorer 10+ | Chrome | Firefox